Can IgA (Immunoglobulin A) Nephropathy occur in response to inhaled toxins?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IgA Nephropathy and Inhaled Toxins

There is no established causal relationship between inhaled toxins and IgA nephropathy in the medical literature, though rare case reports suggest possible associations with specific pulmonary conditions.

Evidence for Association

The available evidence does not support inhaled toxins as a recognized trigger for IgA nephropathy. However, one isolated case report describes a potential pulmonary-renal connection:

  • A single case documented bronchiolitis obliterans (an obstructive lung disease) occurring alongside rapidly progressive IgA nephropathy, with extensive IgA deposits found in both lung and kidney tissue 1
  • This case suggested a possible pathogenetic role for IgA in causing tissue injury at both organ sites, though this association has not been replicated in subsequent literature 1

Recognized Associations with IgA Nephropathy

IgA nephropathy is primarily understood through different pathogenic mechanisms that do not involve inhaled toxins:

Established Pathogenesis

  • The definitive diagnostic feature is mesangial dominant or co-dominant IgA deposits on kidney biopsy, resulting from immune complexes containing specific O-glycoforms of IgA1 2, 3
  • The disease appears to involve dysregulation of mucosal immunity rather than environmental toxin exposure 4, 3

Known Secondary Associations

  • IgA nephropathy has been reported as an extra-intestinal manifestation of inflammatory bowel disease, suggesting shared inflammatory pathways rather than toxin exposure 5
  • Some lung diseases have been associated with IgA nephropathy, including pulmonary hemorrhage and sarcoidosis, but these represent immune-mediated processes rather than toxin-induced injury 1

Clinical Implications

When evaluating a patient with suspected IgA nephropathy, focus on established risk factors rather than inhaled toxin exposure:

  • Look for presenting features of hematuria (with or without proteinuria), hypertension, and impaired renal function 2, 6
  • Assess for inflammatory bowel disease or other systemic conditions that may be associated with secondary IgA deposition 5
  • Kidney biopsy remains the gold-standard diagnostic test, with electron microscopy revealing electron-dense deposits in the mesangium 2

Important Caveat

While inhaled corticosteroids (budesonide and beclomethasone) are used to treat respiratory manifestations in inflammatory bowel disease patients, this reflects treatment of pulmonary complications rather than a causal relationship between inhaled substances and IgA nephropathy 5

References

Research

Bronchiolitis obliterans and IgA nephropathy. A new cause of pulmonary-renal syndrome.

American journal of respiratory and critical care medicine, 1997

Guideline

IgA Nephropathy Pathogenesis and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

IgA Nephropathy: Core Curriculum 2021.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021

Research

IgA nephropathy in adults-treatment standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.